Nutraceutix’ new moniker
This article was originally published in The Tan Sheet
Executive Summary
Name change to SCOLR approved by shareholders July 2. New name, which stands for Self Correcting Oral Linear Release, is aimed at better reflecting Redmond, Wash.-based firm's shift in focus from the nutraceutical business to drug delivery technology development (1"The Tan Sheet" June 3, 2002, In Brief)...
You may also be interested in...
Nutraceutix name change
Shareholders will be asked to approve company name change to SCOLR at annual meeting July 2. SCOLR, pronounced "scholar," stands for Self Correcting Oral Linear Release, which is the technology behind Nutraceutix' CDT drug delivery platform. In proxy materials filed with SEC, firm says new name better reflects "shift in focus from its nutraceutical business to developing its drug delivery technology." In March, Nutraceutix licensed to Archer Daniels Midland exclusive, worldwide rights to market ingredients incorporating CDT technology to supplement manufacturers (1"The Tan Sheet" April 8, 2002, p. 13)...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.